TeneoBio
TeneoBio is a biotechnology company that specializes in the development of human heavy chain antibodies. It has several products in pre-clinical and clinical development for the treatment of multiple myeloma, prostate cancer, and immune disorders. TeneoBio’s antibody discovery engine is based on UniRat™, a proprietary heavy chain only, human immunoglobulin transgenic rat.
Industries
biotechnology
health-care
pharmaceutical
Nr. of Employees
small (1-50)
TeneoBio
Patents
Anti-B-cell maturation antigen chimeric antigen receptors with human domains
US-12570717-B2
View DetailsTransgenic non-human animals producing modified heavy chain-only antibodies
US-12495776-B2
View Details
Anti-B-cell maturation antigen chimeric antigen receptors with human domains
US-12570717-B2
View DetailsTransgenic non-human animals producing modified heavy chain-only antibodies
US-12495776-B2
View Details